Addressing Care Disparities for Veterans: Tackling Barriers and Identifying Solutions
The Association of Cancer Care Centers (ACCC) Veterans Care initiative equips multidisciplinary oncology professionals with practical strategies to better serve the nation’s Veterans. Explore how to coordinate care with the U.S. Department of Veterans Affairs (VA), increase awareness of clinical trials for Veterans, and navigate VA enrollment pathways. Access best practices and discover curated patient resources for high-priority cancers—including lung, prostate, head and neck, bladder, and chronic lymphocytic leukemia (CLL)—through the Veterans Care Resource Library. Explore insights from community and VA surveys that reveal the barriers Veterans face in accessing cancer care and connect with like-minded professionals dedicated to delivering high-quality care for this unique patient population.
Veterans Care Resource Library
Explore curated resources to support veterans with cancer and their families and caregivers. This collection contains patient guides, research articles, videos, and tools that address common risk factors for veterans, barriers to treatment, and how to navigate care through the U.S. Department of Veterans Affairs. ACCC has compiled these resources developed by oncology experts across federal agencies, nonprofit organizations, and leading cancer care centers.
The NCCN hosted a patient advocacy summit as a forum for providers, advocates, and industry members to discuss the varied and unique cancer care needs of Veterans and first responders.
In honor of the great sacrifice of Veterans and first responders and in pursuit of improving awareness, health literacy, and availability of assistance programs, the NCCN hosted a patient advocacy summit on December 9, 2025, in the nation’s capital.
In partnership with the Association of VA Hematology/Oncology (AVAHO), the Bladder Cancer Advocacy Network (BCAN), the Head and Neck Cancer Alliance (HNCA), the Leukemia and Lymphoma Society (LLS), LUNGevity Foundation, and the Nurses Organization of Veterans Affairs (NOVA).
This program was made possible with support from AstraZeneca, Gilead, Lilly, Pfizer, and Regeneron.
